| P50 | author | Jacob Selhub | Q111743497 |
| | Mary Frances Picciano | Q112625463 |
| | Paul F Jacques | Q58418672 |
| P2093 | author name string | Lydia Sakakeeny | |
| | Martha Savaria Morris | |
| P2860 | cites work | Estimation of average concentration in the presence of nondetectable values | Q23920166 |
| | Inflammation causes tissue-specific depletion of vitamin B6. | Q24812811 |
| | Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis | Q24813029 |
| | Atherosclerosis — An Inflammatory Disease | Q26776972 |
| | Cytokines in acute and chronic inflammation | Q28645928 |
| | Homocysteine metabolism | Q33711793 |
| | Cardiovascular morbidity and mortality in rheumatoid arthritis | Q33806651 |
| | Vitamin B-6: a status report | Q34262523 |
| | Hyperhomocysteinemia and its role in the development of atherosclerosis | Q35209853 |
| | Inflammation-mediated rheumatic diseases and atherosclerosis | Q35549285 |
| | Inflammation, the complement system and the diseases of aging | Q36273979 |
| | What does minor elevation of C-reactive protein signify? | Q36380443 |
| | Biological therapies in autoimmune chronic inflammatory diseases (ACIDs). | Q36403567 |
| | Serum C-reactive protein as a marker for wellness assessment | Q36472113 |
| | B6-responsive disorders: a model of vitamin dependency | Q36501317 |
| | Multivitamin-multimineral supplements: who uses them? | Q36701918 |
| | Predictors of vitamin B6 and folate concentrations in older persons: the InCHIANTI study | Q37104249 |
| | Inflammation, ageing and cancer. | Q37232162 |
| | Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective | Q37300177 |
| | Premature atherosclerotic cardiovascular disease and systemic lupus erythematosus from bedside to bench | Q37304208 |
| | Cardiovascular risk in rheumatoid arthritis | Q37459157 |
| | Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment | Q38144954 |
| | Diseases associated with defects in vitamin B6 metabolism or utilization | Q39661637 |
| | Pyridoxine deficiency and cytotoxicity of T lymphocytes in vitro | Q39858261 |
| | Novel functions of vitamin B6. | Q40609853 |
| | Vitamin B-6 requirements of elderly men and women | Q41934464 |
| | URINARY EXCRETION OF PYRIDOXINE AND 4-PYRIDOXIC ACID IN RHEUMATOID ARTHRITIS. | Q41943202 |
| | Low vitamin B6 status in patients with acute myocardial infarction | Q42505284 |
| | Vitamin B-6 deficiency impairs interleukin 2 production and lymphocyte proliferation in elderly adults | Q43611352 |
| | Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels | Q43636903 |
| | Homogeneous, nonradioactive, enzymatic assay for plasma pyridoxal 5-phosphate. | Q44113717 |
| | Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid. | Q44205545 |
| | Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants | Q44277481 |
| | Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response. | Q44324666 |
| | Plasma pyridoxal 5'-phosphate concentration is correlated with functional vitamin B-6 indices in patients with rheumatoid arthritis and marginal vitamin B-6 status | Q44388764 |
| | Low Vitamin B6 but Not Homocyst(e)ine Is Associated With Increased Risk of Stroke and Transient Ischemic Attack in the Era of Folic Acid Grain Fortification | Q44435312 |
| | Plasma pyridoxal-5'-phosphate levels in myocardial infarction | Q44525669 |
| | Inflammation, homocysteine, and vitamin B6 status after ischemic stroke | Q44681253 |
| | Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy | Q44716963 |
| | Compartmentalization of pyridoxal-5'-phosphate during the acute phase of myocardial infarction | Q44932423 |
| | The relationship between plasma and red cell concentrations of vitamins thiamine diphosphate, flavin adenine dinucleotide and pyridoxal 5-phosphate following elective knee arthroplasty. | Q45068865 |
| | Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized subs | Q45166661 |
| | Effects of pantothenic acid, pyridoxine and thiamine deficiencies upon antibody formation to influenza virus PR-8 in rats | Q45718468 |
| | Effect of pyridoxine deficiency upon delayed hypersensitivity in guinea pigs | Q46186468 |
| | The relationship between plasma and red cell B-vitamin concentrations in critically-ill patients | Q46627119 |
| | Effects of vitamin B6 deficiency on cytokine levels and lymphocytes in mice | Q47905572 |
| | Relation between pyridoxal and pyridoxal phosphate concentrations in plasma, red cells, and white cells in patients with critical illness. | Q50642647 |
| | Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. | Q51035720 |
| | Improved vitamin B-6 status is positively related to lymphocyte proliferation in young women consuming a controlled diet. | Q51539875 |
| | Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group. | Q51561565 |
| | Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. | Q51568729 |
| | Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline | Q56092268 |
| | Foreword | Q57336973 |
| | Atherosclerosis is an inflammatory disease | Q58197660 |
| | Abnormal vitamin b6status in rheumatoid cachexia association with spontaneous tumor necrosis factor α production and markers of inflammation | Q61663333 |
| | Is type 2 diabetes a chronic inflammatory/autoimmune disease? | Q64950621 |
| | Considerations in the use of B6 vitamers in hematologic disorders: I. Red cell transport and metabolism of pyridoxal | Q70281540 |
| | Prevention of myocardial infarction by vitamin B6 | Q70886242 |
| | The effect of vitamin B6 deficiency on cytotoxic immune responses of T cells, antibodies, and natural killer cells, and phagocytosis by macrophages | Q71005957 |
| | A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians | Q71458714 |
| | Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease | Q71807467 |
| | Vitamin B-6 requirement and status assessment of young women fed a high-protein diet with various levels of vitamin B-6 | Q74157001 |
| | Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging | Q75220942 |
| | Can dietary supplements with folic acid or vitamin B6 reduce cardiovascular risk? Design of clinical trials to test the homocysteine hypothesis of vascular disease | Q77907697 |
| | Present status of Vitamin B6 metabolism | Q78828425 |
| | Low pyridoxal 5'-phosphate is associated with increased risk of coronary artery disease | Q79256266 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin B | Q183206 |
| | inflammation | Q101991 |
| P304 | page(s) | 103-110 | |
| P577 | publication date | 2009-11-11 | |
| P1433 | published in | Journal of Nutrition | Q3186931 |
| P1476 | title | Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status | |
| P478 | volume | 140 | |